Copyright Reports & Markets. All rights reserved.

Global Parkinson's Disease Treatments Market Professional Survey Report 2019

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Parkinson's Disease Treatments Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Dopamine Agonists
    • 1.4.3 Levodopa
    • 1.4.4 Glutamate Antagonist
    • 1.4.5 Apomorphine
    • 1.4.6 COMT Inhibitors Anticholinergics
    • 1.4.7 MAO-B Inhibitors
    • 1.4.8 Other Drugs
  • 1.5 Market by Application
    • 1.5.1 Global Parkinson's Disease Treatments Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Healthcare Institutes
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Parkinson's Disease Treatments Market Perspective (2015-2026)
  • 2.2 Global Parkinson's Disease Treatments Growth Trends by Regions
    • 2.2.1 Parkinson's Disease Treatments Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Parkinson's Disease Treatments Historic Market Share by Regions (2015-2020)
    • 2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Parkinson's Disease Treatments Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Parkinson's Disease Treatments Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Parkinson's Disease Treatments Players by Market Size
    • 3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2015-2020)
    • 3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Parkinson's Disease Treatments Market Concentration Ratio
    • 3.2.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2019
  • 3.3 Parkinson's Disease Treatments Key Players Head office and Area Served
  • 3.4 Key Players Parkinson's Disease Treatments Product Solution and Service
  • 3.5 Date of Enter into Parkinson's Disease Treatments Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2015-2020)
  • 4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Parkinson's Disease Treatments Market Size by Application (2015-2020)
  • 5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Parkinson's Disease Treatments Market Size (2015-2020)
  • 6.2 Parkinson's Disease Treatments Key Players in North America (2019-2020)
  • 6.3 North America Parkinson's Disease Treatments Market Size by Type (2015-2020)
  • 6.4 North America Parkinson's Disease Treatments Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Parkinson's Disease Treatments Market Size (2015-2020)
  • 7.2 Parkinson's Disease Treatments Key Players in Europe (2019-2020)
  • 7.3 Europe Parkinson's Disease Treatments Market Size by Type (2015-2020)
  • 7.4 Europe Parkinson's Disease Treatments Market Size by Application (2015-2020)

8 China

  • 8.1 China Parkinson's Disease Treatments Market Size (2015-2020)
  • 8.2 Parkinson's Disease Treatments Key Players in China (2019-2020)
  • 8.3 China Parkinson's Disease Treatments Market Size by Type (2015-2020)
  • 8.4 China Parkinson's Disease Treatments Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Parkinson's Disease Treatments Market Size (2015-2020)
  • 9.2 Parkinson's Disease Treatments Key Players in Japan (2019-2020)
  • 9.3 Japan Parkinson's Disease Treatments Market Size by Type (2015-2020)
  • 9.4 Japan Parkinson's Disease Treatments Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Parkinson's Disease Treatments Market Size (2015-2020)
  • 10.2 Parkinson's Disease Treatments Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Parkinson's Disease Treatments Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Parkinson's Disease Treatments Market Size by Application (2015-2020)

11 India

  • 11.1 India Parkinson's Disease Treatments Market Size (2015-2020)
  • 11.2 Parkinson's Disease Treatments Key Players in India (2019-2020)
  • 11.3 India Parkinson's Disease Treatments Market Size by Type (2015-2020)
  • 11.4 India Parkinson's Disease Treatments Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Parkinson's Disease Treatments Market Size (2015-2020)
  • 12.2 Parkinson's Disease Treatments Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Parkinson's Disease Treatments Market Size by Type (2015-2020)
  • 12.4 Central & South America Parkinson's Disease Treatments Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 GSK
    • 13.1.1 GSK Company Details
    • 13.1.2 GSK Business Overview
    • 13.1.3 GSK Parkinson's Disease Treatments Introduction
    • 13.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2015-2020))
    • 13.1.5 GSK Recent Development
  • 13.2 Merck
    • 13.2.1 Merck Company Details
    • 13.2.2 Merck Business Overview
    • 13.2.3 Merck Parkinson's Disease Treatments Introduction
    • 13.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.2.5 Merck Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview
    • 13.3.3 Novartis Parkinson's Disease Treatments Introduction
    • 13.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 Teva
    • 13.4.1 Teva Company Details
    • 13.4.2 Teva Business Overview
    • 13.4.3 Teva Parkinson's Disease Treatments Introduction
    • 13.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.4.5 Teva Recent Development
  • 13.5 Boehringer Ingelheim
    • 13.5.1 Boehringer Ingelheim Company Details
    • 13.5.2 Boehringer Ingelheim Business Overview
    • 13.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction
    • 13.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.5.5 Boehringer Ingelheim Recent Development
  • 13.6 Impax
    • 13.6.1 Impax Company Details
    • 13.6.2 Impax Business Overview
    • 13.6.3 Impax Parkinson's Disease Treatments Introduction
    • 13.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.6.5 Impax Recent Development
  • 13.7 Abbvie
    • 13.7.1 Abbvie Company Details
    • 13.7.2 Abbvie Business Overview
    • 13.7.3 Abbvie Parkinson's Disease Treatments Introduction
    • 13.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.7.5 Abbvie Recent Development
  • 13.8 Bausch Health
    • 13.8.1 Bausch Health Company Details
    • 13.8.2 Bausch Health Business Overview
    • 13.8.3 Bausch Health Parkinson's Disease Treatments Introduction
    • 13.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.8.5 Bausch Health Recent Development
  • 13.9 Lundbeck
    • 13.9.1 Lundbeck Company Details
    • 13.9.2 Lundbeck Business Overview
    • 13.9.3 Lundbeck Parkinson's Disease Treatments Introduction
    • 13.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.9.5 Lundbeck Recent Development
  • 13.10 Sun Pharma
    • 13.10.1 Sun Pharma Company Details
    • 13.10.2 Sun Pharma Business Overview
    • 13.10.3 Sun Pharma Parkinson's Disease Treatments Introduction
    • 13.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 13.10.5 Sun Pharma Recent Development
  • 13.11 Wockhardt
    • 10.11.1 Wockhardt Company Details
    • 10.11.2 Wockhardt Business Overview
    • 10.11.3 Wockhardt Parkinson's Disease Treatments Introduction
    • 10.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 10.11.5 Wockhardt Recent Development
  • 13.12 Acadia
    • 10.12.1 Acadia Company Details
    • 10.12.2 Acadia Business Overview
    • 10.12.3 Acadia Parkinson's Disease Treatments Introduction
    • 10.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 10.12.5 Acadia Recent Development
  • 13.13 UCB
    • 10.13.1 UCB Company Details
    • 10.13.2 UCB Business Overview
    • 10.13.3 UCB Parkinson's Disease Treatments Introduction
    • 10.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2015-2020)
    • 10.13.5 UCB Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Parkinson's Disease Treatments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    GSK
    Merck
    Novartis
    Teva
    Boehringer Ingelheim
    Impax
    Abbvie
    Bausch Health
    Lundbeck
    Sun Pharma
    Wockhardt
    Acadia
    UCB

    Market segment by Type, the product can be split into
    Dopamine Agonists
    Levodopa
    Glutamate Antagonist
    Apomorphine
    COMT Inhibitors Anticholinergics
    MAO-B Inhibitors
    Other Drugs
    Market segment by Application, split into
    Hospitals
    Healthcare Institutes
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now